Analysts Viewpoint
A Guide To The Risks Of Investing In Tourmaline Bio Inc (TRML)
Tourmaline Bio Inc’s recently made public that its Director MCDADE MARK acquired Company’s shares for reported $3.25 million on Jan
Menu
Tourmaline Bio Inc’s recently made public that its Director MCDADE MARK acquired Company’s shares for reported $3.25 million on Jan
Tourmaline Bio Inc’s recent filing unveils that its Director MCDADE MARK acquired Company’s shares for reported $3.25 million on Jan
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tourmaline Bio